Downregulation of Crystallin Lambda 1 is a New Independent Prognostic Marker in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC), the most prevalent kidney cancer subtype, has a high mortality rate. Crystallin lambda 1 (CRYL1) encodes an enzyme that catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in uronate cycle. CRYL1 dysregulation has been linked to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Lingsong, Ding, Guodong, Zhou, Yang, Zhu, Haiyuan, Jiang, Huiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563328/
https://www.ncbi.nlm.nih.gov/pubmed/36246497
http://dx.doi.org/10.2147/PGPM.S382564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563328/
https://www.ncbi.nlm.nih.gov/pubmed/36246497
http://dx.doi.org/10.2147/PGPM.S382564

Ejemplares similares